Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,416 | 104,991 | 31,232 | 23,278 | 26,119 |
| Marketable Securities | 18,898 | 14,629 | 32,859 | 23,432 | 35,563 |
| Receivables | 1,352 | 1,130 | 4,039 | 1,146 | 8,119 |
| TOTAL | $89,525 | $121,451 | $69,628 | $49,116 | $70,364 |
| Non-Current Assets | |||||
| PPE Net | 72 | 103 | 70 | 44 | 73 |
| TOTAL | $72 | $103 | $70 | $44 | $73 |
| Total Assets | $89,597 | $121,553 | $69,698 | $49,160 | $70,436 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,232 | 8,022 | 2,972 | 2,412 | 7,328 |
| Accrued Expenses | 4,030 | 7,776 | 4,832 | 5,789 | 7,910 |
| TOTAL | $5,520 | $16,055 | $7,804 | $15,402 | $27,583 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 257 | 257 | 0 | 7,201 | 12,345 |
| Other Non-Current Liabilities | 0 | 0 | 1,267 | 0 | 0 |
| TOTAL | $N/A | $N/A | $1,267 | $N/A | $7,201 |
| Total Liabilities | $5,520 | $16,055 | $9,070 | $15,402 | $34,784 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,347 | 29,975 | 29,904 | 29,835 | 29,778 |
| Common Shares | 30 | 30 | 30 | 30 | 30 |
| Retained earnings | -99,871 | -74,588 | -116,927 | -139,999 | -133,140 |
| Other shareholders' equity | -3 | -18 | 20 | 12 | 222 |
| TOTAL | $84,077 | $105,498 | $60,628 | $33,758 | $35,652 |
| Total Liabilities And Equity | $89,597 | $121,553 | $69,698 | $49,160 | $70,436 |